Skip to main content
. 2006 Apr 19;2006(2):CD005321. doi: 10.1002/14651858.CD005321.pub2

Comparison 4. BioHy (Arthrease, Euflexxa) versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Safety: total withdrawals overall 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.1 14 to 26 weeks post‐injection 1 49 Risk Ratio (M‐H, Fixed, 95% CI) 0.72 [0.18, 2.89]
2 Safety: number of adverse events for injection site pain 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
2.1 14 to 26 weeks post‐injection 1 49 Risk Ratio (M‐H, Fixed, 95% CI) 1.57 [0.95, 2.59]